Atlas›Toolkit›Client card
When a client mentions it · IX-009

NMDA-modulating combination antidepressant (dextromethorphan-bupropion)

Domain IX · Biomedical, neuro & digital · 2022 · USA

Full guide

What it is

Dextromethorphan-bupropion is a prescription medicine, not a psychotherapy. A prescriber decides on it, prescribes it and monitors it. A psychotherapist does not deliver it. This guide is for the psychotherapist working alongside the prescriber. General antidepressant collaboration…

Format

  • There are no psychotherapy "phases" belonging to this medicine. The framework below sets out the course of prescriber-led treatment as labelling describes it, and the psychotherapist's tasks at each stage. Session count and format follow whatever psychotherapy the client is already receiving.…
  • Version followed: US FDA Prescribing Information for AUVELITY (dextromethorphan HBr and bupropion HCl) extended-release tablets, revised 04/2026, and the accompanying Medication Guide as posted in April 2026; Axsome Therapeutics' approval announcements of 19 August 2022 (major depressive disorder)…

Who practises it, and how they are trained or regulated

  • Who delivers it and regulatory status
  • Prescriber: a licensed prescriber within their scope of practice. Which professions may prescribe is set by state law and is not covered in the sources.
  • EU (EMA), UK (MHRA), Canada, Australia, Germany: none of the sources recorded a marketing authorisation. Clients outside the US should not assume it is available or licensed there. Check the national medicines regulator.

Questions to explore with your client

  • What drew you to it, and what are you hoping it will change?
  • Does it involve any substance, plant preparation, remedy or supplement? Has your doctor or prescriber been told, especially about any medication you take?
  • Does it involve fasting, a special diet or 'detox'? Have you discussed this with your doctor?
  • How do you and the practitioner understand what is happening, in spiritual or cultural terms? Is that a source of comfort, worry, or both?
  • Does it use a device, heat, cold, water or a physical procedure? Has a medical professional checked that it is safe for you?
  • Who runs it, and what training or registration do they hold?
  • What actually happens in a session or meeting, and how often?
  • What does it cost, and is there pressure to commit to more?
  • How do you feel afterwards, in the hours and days that follow?
  • Does it fit with, or clash with, the work we do here?

What practitioners of it watch for

  • caregiver exhaustion, safety at home, and falls.
  • shame-driven non-disclosure, and binge-drinking patterns.
  • rapid activation alongside persistent hopelessness. Escalate.
  • return of depressive symptoms or suicidality. Route promptly.
  • crediting every gain to the pill, or blaming every setback on it.

When to involve someone else

  • New or worsening physical symptoms, or advice to stop or change prescribed medication: involve the client's doctor or prescriber.
  • Signs of coercion, isolation from family and friends, escalating costs or secrecy: discuss openly and consider safeguarding.
  • A crisis or thoughts of suicide: follow your crisis protocol. In the US, call or text 988; in the UK and Ireland, Samaritans on 116 123.

Drawn automatically from the guide's own sections. Stay curious: neither endorse nor dismiss what the client values, and check anything that matters against the full guide and its sources. Not medical advice.